The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons.

Department of Psychological Medicine, The Henry Wellcome Building for Biomedical Research in Wales, Cardiff University, School of Medicine, Heath Park, Cardiff, UK.
Molecular Psychiatry (Impact Factor: 15.15). 06/2006; 11(5):446-58. DOI: 10.1038/
Source: PubMed

ABSTRACT The enzyme catechol-O-methyl transferase (COMT), identified in the 1950s, is involved in catabolism of monoamines that are influenced by psychotropic medications, including neuroleptics and antidepressants. The COMT gene lies in a chromosomal region of interest for psychosis and bipolar spectrum disorder and a common polymorphism within the gene alters the activity of the enzyme. As a consequence, COMT has been one of the most studied genes for psychosis. On the basis of prior probabilities it would seem surprising if functional variation at COMT did not have some influence either on susceptibility to psychiatric phenotypes, modification of the course of illness or moderation of response to treatment. There is now robust evidence that variation at COMT influences frontal lobe function. However, despite considerable research effort, it has not proved straightforward to demonstrate and characterise a clear relationship between genetic variation at COMT and psychiatric phenotypes. It is of course, possible that COMT will turn out to be an unusually intractable case but it seems more likely that the experiences with this gene will provide a foretaste of the complexity of genotype-phenotype relationships that will be found for psychiatric traits. In this review, we consider the current state of evidence and the implications both for further studies of COMT and more generally for studies of other genes.

  • [Show abstract] [Hide abstract]
    ABSTRACT: While antidepressant drugs are beneficial to many patients, current treatments for depression remain suboptimal. Up to half of patients with a major depressive episode fail to achieve remission with a first line antidepressant treatment. Identification of the molecular mechanisms that dictate whether a patient will successfully respond to a particular antidepressant treatment while tolerating its side effects is a major challenge in biological psychiatry research but is also one that shows great promise. This review summarises data from both clinical and preclinical studies that point to a role of specific genes in the response and resistance to antidepressant therapeutics. Moreover, we discuss how such findings have increased our understanding of the mechanism of action of antidepressant drugs. Finally, we comment on how this information may potentially influence the future development of personalized medicine approaches for the treatment of depression.
    Pharmacology Biochemistry and Behavior 10/2013; 123. DOI:10.1016/j.pbb.2013.10.015 · 2.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dopaminergic and serotonergic systems have been implicated in PTSD. The present study evaluated the association of four catechol-O-methyltransferase (COMT) gene loci, and the joint effect of COMT and tryptophan hydroxylase 2 (TPH2) genes on PTSD symptoms. Subjects included 200 Caucasian Armenian adults exposed to the 1988 Spitak earthquake from 12 multigenerational (3-5 generations) families. Instruments used included the UCLA PTSD Reaction Index based on DSM-5 criteria, and the Beck Depression Inventory. The adjusted heritabilitiy of vulnerability to DSM-5 based PTSD symptoms was 0.60 (p<10(-4)). There was a significant association of the COMT allele rs4633C with total PTSD (p<0.03), and D category (p<0.04) (negative alterations in cognitions and mood) severity scores, but not with C category (avoidance) scores. There was no genetic correlation between C and D category severity scores. COMT allele rs4633C and the TPH-2 allele rs11178997T together accounted for 7% of the variance in PTSD severity scores (p<0.001). None of the COMT alleles were associated with depression. The ratings of earthquake exposure and prior trauma may have been subject to recall bias. The findings may not be generalizable to other ethnic/racial populations. COMT allele rs4633C may be causally related and/or is in linkage disequilibrium with gene(s) that are causally related to PTSD symptoms. Carriers of these COMT and the TPH-2 alleles may be at increased risk for PTSD. The findings provide biological support for dividing DSM-IV category C symptoms into DSM-5 categories C and D. Copyright © 2014. Published by Elsevier B.V.
    Journal of Affective Disorders 10/2014; 172C:472-478. DOI:10.1016/j.jad.2014.10.034 · 3.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT This essay assesses the two most significant changes in psychology over the past century: the attempt to localize psychological phenomena in restricted brain sites and the search for genetic contributions to behavior and psychopathology. Although there are advantages to these new developments, they are accompanied by some questionable assumptions. Because the investigators in these domains often relate variation in their biological measures to variation in personality traits evaluated with questionnaires, an analysis of the unique properties of the verbal-report questionnaires is presented. It is suggested that future research on human personality should try to combine semantic reports with behaviors and biological data in order to arrive at more fruitful constructs.
    Perspectives on Psychological Science 12/2007; 2(4). DOI:10.1111/j.1745-6916.2007.00049.x · 4.89 Impact Factor


Available from